"Leva Capital is thrilled to announce the addition of iApotheca into our investment portfolio," said Eddie Gobran, Managing Partner. "Their strategy aligns with our vision of investing in health technology that will improve the healthcare experience for Canadians. We are confident in iApotheca's team to execute their strategy and deliver a great experience to pharmacies across Canada."
This funding will enable RetiSpec to accelerate the commercialization of its groundbreaking technology aimed at early detection of Alzheimer's disease.
